Categories

Volume 4 Issue 6 (November - December, 2016)

Original Articles

EVALUATION OF STRENGTH OF MAGNETIC RESONANCE IMAGING IN PATIENTS UNDERGOING TREATMENT FOR RHEUMATOID ARTHRITIS- A RETROSPECTIVE ANALYSIS
Nitin Dashrath Wadhwani, Niranjan Bapusaheb Patil

Background: Clinical course and progression of RA has been shown to be modified by biological treatment, mainly with anti‐tumour necrosis factor (TNF) α agents. Magnetic resonance imaging (MRI) has been shown to be a highly sensitive technique for the detection of inflammatory soft tissue proliferation, bone oedema and early erosions, and since the implementation of MRI into the clinical practice, numerous cross-sectional papers concerning the MRI-detectable features of RA have been published. Hence; we assessed the effectiveness of MRI scans in patients with rheumatoid arthritis. Materials & methods: The present study was conducted in the department of the radiology of the institution and included retrospective assessment 600 patients with RA who underwent clinical assessment with MRI. Synovitis was scored on a 0–3 scale at three different locations: radioulnar joint, radiocarpal joint and intercarpal–carpometacarpal joints (total maximum score 9). A score of 0 is normal, with no enhancement or enhancement up to the thickness of normal synovium, while the scores from 1 to 3 (mild, moderate, severe) refer to increments of one-third of the presumed maximum volume of enhancing tissue in the synovial compartment. Blood samples were collected at some time prior to the MRIs and the presence or absence of RF and serum levels of CRP and anti-CCP antibodies were determined. All the results were analyzed by SPSS software. Chi-square test was used for the assessment of level of significance.  Results: Percentage of males in group 1 and group 2 was 26 and 21 percent respectively. Mean duration of disease in group 1 and group was 141 and 99 months respectively. Mean number of tender joints in group 1 and group 2 was 7.5 and 10.1 respectively. Significant results were obtained while comparing the mean duration of diseases and mean number of tender joints in group 1 and group 2 respectively. In patients with less than 3 years of diseases duration, in 8.5 percent of the patients in group 1, treatment was unchanged. Conclusion: Useful information regarding the treatment therapy is provided by a single MRI done during the phase of treatment.
Key words:  MRI, Rheumatoid arthritis

 
Html View | Download PDF | Current Issue